These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8641043)

  • 1. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

  • 4. Nifedipine study.
    Lichtlen PR
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641040
    [No Abstract]   [Full Text] [Related]  

  • 5. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 7. Nimodipine in patients with heart disease.
    Roine RO
    Circulation; 1996 Apr; 93(7):1472-3; author reply 1473. PubMed ID: 8641041
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of sublingual nifedipine: a continuing concern.
    Messerli FH; Grossman E
    Arch Intern Med; 1999 Oct; 159(19):2259-60. PubMed ID: 10547164
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the hypotensive effects of finoptin and corinfar after their sublingual administration].
    Kolesova MA; Orlov VM
    Klin Med (Mosk); 1988 Feb; 66(2):38-41. PubMed ID: 3286995
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
    Yusuf S
    Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648
    [No Abstract]   [Full Text] [Related]  

  • 14. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 15. [A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?].
    Wenzel UO; Pfalzer B; Meinertz T; Stahl RA
    Internist (Berl); 1999 Feb; 40(2):205-9. PubMed ID: 10097979
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of calcium antagonists (sublingually) in the treatment of hypertensive crises].
    Shcherban' NN; Pakhomova SP; Kalenskiĭ VKh; Podstavnaia LI
    Klin Med (Mosk); 1988 Apr; 66(4):37-9. PubMed ID: 3398448
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hemodynamic effects of lomir and adalat in patients with postoperative arterial hypertension].
    Eremenko AA; Ziuliaeva TP; Bozh'eva LV; Borisov RIu
    Anesteziol Reanimatol; 1999; (5):63-6. PubMed ID: 10560156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists and their impact on coronary risk].
    Rodríguez Moreno C
    Med Clin (Barc); 1998 Feb; 110(6):237. PubMed ID: 9547737
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium antagonists: safe or unsafe?].
    Rosendaal FR; Psaty BM; Furberg CD
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):916-8. PubMed ID: 8676969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.